Campbell & Co Investment Adviser’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$895K Buy
+13,285
New +$885K 0.05% 585
2025
Q4
Sell
-9,355
Closed -$629K 1195
2025
Q3
$629K Sell
9,355
-16,421
-64% -$1.3M 0.05% 625
2025
Q2
$2.25M Sell
25,776
-730
-3% -$57.2K 0.14% 215
2025
Q1
$1.81M Buy
+26,506
New +$2.16M 0.14% 226
2024
Q4
Sell
-14,791
Closed -$992K 1122
2024
Q3
$992K Buy
14,791
+4,154
+39% +$341K 0.07% 443
2024
Q2
$1.21M Sell
10,637
-2,345
-18% -$296K 0.1% 291
2024
Q1
$1.8M Buy
12,982
+5,374
+71% +$676K 0.16% 172
2023
Q4
$944K Sell
7,608
-7,730
-50% -$790K 0.09% 414
2023
Q3
$1.43M Buy
15,338
+10,983
+252% +$1.24M 0.17% 166
2023
Q2
$560K Buy
4,355
+935
+27% +$113K 0.1% 376
2023
Q1
$397K Buy
+3,420
New +$383K 0.07% 503
2022
Q4
Sell
-3,102
Closed -$250K 815
2022
Q3
$250K Buy
+3,102
New +$263K 0.06% 542
2022
Q1
Sell
-5,400
Closed -$725K 741
2021
Q4
$725K Buy
+5,400
New +$776K 0.25% 108
2021
Q3
Sell
-6,000
Closed -$641K 630
2021
Q2
$641K Buy
+6,000
New +$576K 0.26% 98
2020
Q1
Sell
-13,588
Closed -$743K 163
2019
Q4
$743K Buy
+13,588
New +$644K 0.23% 113
2019
Q3
Sell
-12,784
Closed -$479K 639
2019
Q2
$479K Buy
+12,784
New +$402K 0.22% 149
2017
Q1
Sell
-17,140
Closed -$256K 166
2016
Q4
$256K Buy
+17,140
New +$304K 0.79% 55

Other funds holding DXCM

Campbell & Co Investment Adviser's DXCM Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in DexCom (DXCM) in Q2 2026: 13,285 shares worth $895K. The stake represents 0.05% of the portfolio and ranks #585 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in DXCM as recently as Q3 2025.

Campbell & Co Investment Adviser first reported a position in DXCM in Q4 2016 and has held it in 17 quarters since. The position peaked at $2.25M in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Campbell & Co Investment Adviser held 13,285 shares of DexCom worth $895K as of Q2 2026.
  • DexCom was a new Campbell & Co Investment Adviser position in Q2 2026.
  • DexCom made up 0.05% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #585 holding.
  • Campbell & Co Investment Adviser first reported a position in DexCom in Q4 2016 and has held it in 17 quarters since.
  • Campbell & Co Investment Adviser's DexCom position peaked at $2.25M in Q2 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.